Gabriella Marucci Selected Research

Naphthoquinones

11/2020

Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriella Marucci Research Topics

Disease

6	Neoplasms (Cancer) 06/2022 - 11/2010
3	Asthma (Bronchial Asthma) 06/2022 - 03/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2014
3	Neuroinflammatory Diseases 01/2022 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2003
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2008
3	Pain (Aches) 01/2020 - 07/2013
3	Inflammation (Inflammations) 04/2019 - 01/2015
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2022 - 05/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2022
2	Hypersensitivity (Allergy) 01/2020 - 03/2010
2	Neuralgia (Stump Neuralgia) 01/2019 - 07/2013
2	Chronic Pain 01/2017 - 07/2013
1	Atherosclerosis 06/2022
1	Type 2 Diabetes Mellitus (MODY) 06/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Multiple Sclerosis 01/2022
1	Dementia (Dementias) 01/2021
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Carcinogenesis 11/2020
1	Colitis 01/2020
1	Chronic Cough 12/2019
1	Neuroblastoma 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Ischemia 01/2019
1	Stroke (Strokes) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 07/2018
1	Hepatocellular Carcinoma (Hepatoma) 07/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Endocrine System Diseases (Endocrine Diseases) 01/2015
1	Cancer Pain 01/2015
1	Adenocarcinoma 01/2014
1	Migraine Disorders (Migraine) 07/2013
1	Astrocytoma (Pilocytic Astrocytoma) 07/2011
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2010
1	Lower Urinary Tract Symptoms 12/2010
1	Rheumatoid Arthritis 11/2010
1	Dry Eye Syndromes (Dry Eye Syndrome) 11/2010
1	Pathologic Processes 11/2010
1	Focal Cortical Dysplasia 09/2009
1	Epilepsy (Aura) 09/2009

Drug/Important Bio-Agent (IBA)

7	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2022 - 01/2016
5	Adenosine (Adenocard)FDA LinkGeneric 06/2022 - 09/2009
3	LigandsIBA 01/2022 - 07/2013
3	Purinergic P1 Receptor AntagonistsIBA 01/2022 - 05/2018
3	CytokinesIBA 02/2021 - 01/2020
2	Protein Isoforms (Isoforms)IBA 09/2020 - 03/2010
2	AntioxidantsIBA 01/2020 - 01/2019
2	Purinergic P2X3 ReceptorsIBA 04/2019 - 01/2017
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2011 - 03/2010
1	NucleosidesIBA 04/2022
1	Cytostatic AgentsIBA 01/2022
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2022
1	istradefyllineIBA 01/2022
1	InterferonsIBA 02/2021
1	2'-deoxyadenosineIBA 02/2021
1	Adenine FDA LinkGeneric 02/2021
1	InterleukinsIBA 02/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 11/2020
1	Caspase 3 (Caspase-3)IBA 11/2020
1	acetylshikoninIBA 11/2020
1	human ERBB2 proteinIBA 11/2020
1	NaphthoquinonesIBA 11/2020
1	hydroxide ionIBA 09/2020
1	IsoenzymesIBA 09/2020
1	Neuroprotective AgentsIBA 01/2020
1	2,4-dinitrobenzeneIBA 01/2020
1	Adenosine A3 ReceptorIBA 01/2020
1	Sulfonic AcidsIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2020
1	BLU-5937IBA 12/2019
1	GefapixantIBA 12/2019
1	PyridinesIBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	CalciumIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Adenosine A1 ReceptorIBA 01/2019
1	Pharmaceutical PreparationsIBA 07/2018
1	Antineoplastic Agents (Antineoplastics)IBA 07/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2018
1	isofuranodieneIBA 01/2014
1	Bisbenzimidazole (Hoechst 33258)IBA 01/2014
1	Tamsulosin (Flomax)FDA LinkGeneric 12/2010
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2010
1	Rhodopsin (Visual Purple)IBA 03/2010
1	gamma-Aminobutyric Acid (GABA)IBA 09/2009
1	9-ethyladenineIBA 06/2009
1	Adenosine A2 Receptor AntagonistsIBA 06/2009
1	BromineIBA 06/2009
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2008
1	caproctamineIBA 03/2003
1	PolyaminesIBA 03/2003

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2003